Indicative 1 April 2021 prices – 2021 April cycle
Page last updated: 20 January 2021
The spreadsheets below set out the indicative price changes for medicines taking a price disclosure price reduction on 1 April 2021. Advance notice of price changes is provided by the Department to assist companies and other stakeholders in preparation for 1 April 2021 price reductions.
These prices may change if there are changes in prices or listings before 1 April 2021 (e.g. lower price / pricing quantity changes).
The spreadsheets include:
- Legal brand of pharmaceutical item taking a reduction – this is the formal product description in the PBS listing instrument;
- Ex-manufacturer prices - Approved Ex-Manufacturer Price (AEMP) for pricing quantity and the Proportional Ex-Manufacturer Price (PEMP) where pack size is different to pricing quantity. This is the price without fees and mark-ups;
- Price to Pharmacy (PTP) for pack size - this price can also be worked out for an individual product by adding the wholesaler mark-up where applicable;
- Dispensed Price for Maximum Quantity (DPMQ) – dispensed price for supply through community pharmacy, or under s100 arrangement or other specified program. The Dispensed Price for Maximum Amount (DPMA) is given for Efficient Funding of Chemotherapy injectables;
- Manufacturer’s claimed prices and resulting premium – only included for medicines with a premium / other special patient contribution. The method for calculating a premium / other special patient contribution is set out in the National Health Act 1953;
- Trade Product Pack (TPP) - an Australian Medicines Terminology (AMT) description. AMT is used in the Schedule of Pharmaceutical Benefits.
Indicative 1 April 2021 prices – 2021 April cycle (excluding EFC medicines) (Excel 63 KB)
Indicative 1 April 2021 prices – 2021 April cycle (excluding EFC medicines) (PDF 1,145 KB)
Indicative 1 April 2021 prices – 2021 April cycle (EFC only) (Excel 30 KB)
Indicative 1 April 2021 prices – 2021 April cycle (EFC only) (PDF 723 KB)
